EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access

Patient-Centered Economic Burden of Diabetic Macular Edema: Retrospective Cohort Study

Kyungseon Choi iD, Sang Jun Park iD, Hyuna Yoon iD, Seoyoon Choi iD, Yongseok Mun iD, Seok Kim iD, Sooyoung Yoo iD, Se Joon Woo iD, Kyu Hyung Park iD, Junghyun Na iD, Hae Sun Suh iD

JMIR Public Health and Surveillance · 2024

DOI: 10.2196/56741 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift JMIR Public Health and Surveillance, 2024. Verfasst von Kyungseon Choi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Regulatory Science, Graduate School, Kyung Hee University, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Macular Edema, Diabetic Retinopathy, Cost of Illness. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Diabetic macular edema (DME), a leading cause of blindness, requires treatment with costly drugs, such as anti–vascular endothelial growth factor (VEGF) agents. The prolonged use of these effective but expensive drugs results in an incremental economic burden for patients with DME compared with those with diabetes mellitus (DM) without DME. However, there are no studies on the long-term patient-centered economic burden of DME after reimbursement for anti-VEGFs.

Objective

This retrospective cohort study aims to estimate the 3-year patient-centered economic burden of DME compared with DM without DME, using the Common Data Model.

Methods

We used medical data from 1,903,603 patients (2003-2020), transformed and validated using the Observational Medical Outcomes Partnership Common Data Model from Seoul National University Bundang Hospital. We defined the group with DME as patients aged >18 years with nonproliferative diabetic retinopathy and intravitreal anti-VEGF or steroid prescriptions. As control, we defined the group with DM without DME as patients aged >18 years with DM or diabetic retinopathy without intravitreal anti-VEGF or steroid prescriptions. Propensity score matching, performed using a regularized logistic regression with a Laplace prior, addressed selection bias. We estimated direct medical costs over 3 years categorized into total costs, reimbursement costs, nonreimbursement costs, out-of-pocket costs, and costs covered by insurance, as well as healthcare resource utilization. An exponential conditional model and a count model estimated unbiased incremental patient-centered economic burden using generalized linear models and a zero-inflation model.

Results

In a cohort of 454 patients with DME matched with 1640 patients with DM, the economic burden of DME was significantly higher than that of DM, with total costs over 3 years being 2.09 (95% CI 1.78-2.47) times higher. Reimbursement costs were 1.89 (95% CI 1.57-2.28) times higher in the group with DME than with the group with DM, while nonreimbursement costs were 2.54 (95% CI 2.12-3.06) times higher. Out-of-pocket costs and costs covered by insurance were also higher by a factor of 2.11 (95% CI 1.58-2.59) and a factor of 2.01 (95% CI 1.85-2.42), respectively. Patients with DME had a significantly higher number of outpatient (1.87-fold) and inpatient (1.99-fold) visits compared with those with DM (P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Macular EdemaDiabetic RetinopathyCost of IllnessHumansRetrospective StudiesMaleFemaleMiddle AgedAgedCohort StudiesRepublic of KoreaAdultPatient-Centered CareVascular Endothelial Growth Factor AHealth Care Costs

Stichwörter der Autor:innen

Observational Medical Outcomes Partnership Common Data Modelcost of illnessdiabetic macular edemaeconomic burdenpatient-centered careretrospective cohort study

Substanzen

Vascular Endothelial Growth Factor A

Autor:innen und Institutionen

  • Department of Regulatory Science, Graduate School, Kyung Hee University, Seoul, Republic of Korea.
  • Institute of Regulatory Innovation through Science, Kyung Hee University, Seoul, Republic of Korea.
  • Department of Ophthalmology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
  • Department of Ophthalmology, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Republic of Korea.
  • Healthcare ICT Research Center, Office of eHealth Research and Businesses, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
  • Department of Ophthalmology, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Republic of Korea.

ORCID-Profile: Kyungseon Choi, Sang Jun Park, Hyuna Yoon, Seoyoon Choi, Yongseok Mun, Seok Kim, Sooyoung Yoo, Se Joon Woo, Kyu Hyung Park, Junghyun Na, Hae Sun Suh

Zitieren

APA

Choi, K., Park, S. J., Yoon, H., Choi, S., Mun, Y., Kim, S., Yoo, S., Woo, S. J., Park, K. H., Na, J., & Suh, H. S. (2024). Patient-Centered Economic Burden of Diabetic Macular Edema: Retrospective Cohort Study. JMIR Public Health and Surveillance. https://doi.org/10.2196/56741

Vancouver

Choi K, Park SJ, Yoon H, Choi S, Mun Y, Kim S, et al. Patient-Centered Economic Burden of Diabetic Macular Edema: Retrospective Cohort Study. JMIR Public Health and Surveillance. 2024. doi:10.2196/56741

BibTeX
@article{Choi2024,
  author = {Choi, Kyungseon and Park, Sang Jun and Yoon, Hyuna and Choi, Seoyoon and Mun, Yongseok and Kim, Seok and Yoo, Sooyoung and Woo, Se Joon and Park, Kyu Hyung and Na, Junghyun and Suh, Hae Sun},
  title = {Patient-Centered Economic Burden of Diabetic Macular Edema: Retrospective Cohort Study},
  journal = {JMIR Public Health and Surveillance},
  year = {2024},
  doi = {10.2196/56741}
}
Kostenlos starten →